Ligand Pharmaceuticals
LGND
#3449
Rank
S$5.16 B
Marketcap
S$258.82
Share price
1.04%
Change (1 day)
93.34%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Cash on Hand

Cash on Hand as of December 2025 : S$0.97 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has S$0.97 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ligand Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$0.97 B168.37%
2024-12-31S$0.36 B60.86%
2023-12-31S$0.22 B-20.81%
2022-12-31S$0.28 B-38.41%
2021-12-31S$0.46 B-15.23%
2020-12-31S$0.54 B-62.29%
2019-12-31S$1.44 B36.44%
2018-12-31S$1.05 B291.95%
2017-12-31S$0.26 B32.13%
2016-12-31S$0.20 B-27.92%
2015-12-31S$0.28 B28.09%
2014-12-31S$0.22 B992.16%
2013-12-31S$20.24 M33.71%
2012-12-31S$15.14 M-31.39%
2011-12-31S$22.06 M-24.52%
2010-12-31S$29.23 M-60.88%
2009-12-31S$74.73 M-35.22%
2008-12-31S$0.11 B-15.08%
2007-12-31S$0.13 B-48.45%
2006-12-31S$0.26 B82.06%
2005-12-31S$0.14 B-21.13%
2004-12-31S$0.18 B9.07%
2003-12-31S$0.16 B50.93%
2002-12-31S$0.11 B59.79%
2001-12-31S$69.76 M70.12%
2000-12-31S$41.01 M-47.81%
1999-12-31S$78.58 M45.12%
1998-12-31S$54.15 M-48.44%
1997-12-31S$0.10 B115.67%
1996-12-31S$48.7 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$25.79 B 2,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$17.44 B 1,697.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$9.32 B 860.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.71 B 1,107.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$2.52 B 159.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$18.69 B 1,825.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$13.69 B 1,311.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$5.46 B 462.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
S$72.04 M-92.58%๐Ÿ‡บ๐Ÿ‡ธ USA